Literature DB >> 12839844

Breast cancer: do specialists make a difference?

Kristin A Skinner1, James T Helsper, Dennis Deapen, Wei Ye, Richard Sposto.   

Abstract

BACKGROUND: Many believe that breast cancer should be treated by specialists. We studied the effect of surgeon and hospital specialization on survival after breast cancer treatment in a large, well-defined patient population.
METHODS: The Cancer Surveillance Program database for Los Angeles County was reviewed. Between 1990 and 1998, 43,411 cases of breast cancer were diagnosed, of which 29,666 had complete data on surgeon, hospital, and staging information. Patients were stratified on the basis of surgeon and hospital specialization, as well as by age, race, stage, surgical procedure, and surgeon and hospital case volume. An analysis of survival and its dependence on these factors was performed.
RESULTS: Age, race, socioeconomic status, tumor size, nodal status, extent of disease, surgeon specialization, surgeon case volume, and hospital case volume were all associated with 5-year survival after diagnosis of breast cancer. Treatment at a specialty center did not affect survival. Multivariate analysis indicated that type of surgeon was an independent predictor of survival (relative risk,.77), as were both hospital and surgeon case volume.
CONCLUSIONS: Treatment by a surgical oncologist resulted in a 33% reduction in the risk of death at 5 years. The effect of surgical specialization cannot be entirely attributed to volume effects.

Entities:  

Mesh:

Year:  2003        PMID: 12839844     DOI: 10.1245/aso.2003.06.017

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  36 in total

1.  Surgical education in the United States: portents for change.

Authors:  Murray F Brennan; Haile T Debas
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

2.  Are Certified Breast Centers Cost-Effective?

Authors:  Matthias W Beckmann; Mayada R Bani; Christian R Loehberg; Thomas Hildebrandt; Michael G Schrauder; Stefanie Wagner; Peter A Fasching; Michael Patrick Lux
Journal:  Breast Care (Basel)       Date:  2009-08-14       Impact factor: 2.860

3.  Certify it! Breast Cancer Units in Europe.

Authors:  Serban-Dan Costa
Journal:  Breast Care (Basel)       Date:  2009-08-20       Impact factor: 2.860

Review 4.  Health Services Research and Health Economy - Quality Care Training in Gynaecology, with Focus On Gynaecological Oncology.

Authors:  M P Lux; P A Fasching; C R Loehberg; S M Jud; M G Schrauder; M R Bani; F C Thiel; C C Hack; T Hildebrandt; M W Beckmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2011-12       Impact factor: 2.915

5.  Relationship between number of breast cancer operations performed and 5-year survival after treatment for early-stage breast cancer.

Authors:  Mary Ann Gilligan; Joan Neuner; Xu Zhang; Rodney Sparapani; Purushottam W Laud; Ann B Nattinger
Journal:  Am J Public Health       Date:  2007-01-31       Impact factor: 9.308

6.  Does Center Volume Correlate with Survival from Breast Cancer?

Authors:  Anton Scharl; Uwe-Jochen Göhring
Journal:  Breast Care (Basel)       Date:  2009-08-12       Impact factor: 2.860

Review 7.  Shaping the future of surgery: the role of private regulation in determining quality standards.

Authors:  Rachael A Callcut; Tara M Breslin
Journal:  Ann Surg       Date:  2006-03       Impact factor: 12.969

8.  Prevalence and Consequences of Axillary Lymph Node Dissection in the Era of Sentinel Lymph Node Biopsy for Breast Cancer.

Authors:  Tina W F Yen; Purushottam W Laud; Liliana E Pezzin; Emily L McGinley; Erica Wozniak; Rodney Sparapani; Ann B Nattinger
Journal:  Med Care       Date:  2018-01       Impact factor: 2.983

Review 9.  Lung cancer care: the impact of facilities and area measures.

Authors:  Christopher S Lathan
Journal:  Transl Lung Cancer Res       Date:  2015-08

Review 10.  Recent advances in the surgical care of breast cancer patients.

Authors:  Alessandra Mascaro; Massimo Farina; Raffaella Gigli; Carlo E Vitelli; Lucio Fortunato
Journal:  World J Surg Oncol       Date:  2010-01-20       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.